Lightbridge (DE:N7ON)
NASDAQ:N7ON
N7ON Stock Chart & Stats
€12.00
-€0.63(-10.47%)
At close: 4:00 PM EST
€12.00
-€0.63(-10.47%)
Day’s Range― - ―
52-Week Range€7.37 - €24.55
Previous CloseN/A
Volume0.00
Average Volume (3M)48.00
Market Cap
€278.13M
Enterprise Value€81.82M
Total Cash (Recent Filing)€215.67M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding35,147,060
10 Day Avg. Volume139
30 Day Avg. Volume48
Financial Highlights & Ratios
PEG Ratio12.82
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio-21.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance SheetA debt-free balance sheet materially reduces refinancing risk and gives management flexibility to pursue long-duration R&D, regulatory work, and partnership negotiations without fixed interest burdens. This structural financial strength improves survival odds during multi-year commercial validation cycles.
Proprietary Fuel Technology + Licensing ModelOwning a proprietary metallic fuel design and targeting licensing/royalties is a capital-light, scalable model: once qualified, revenue can be earned via partners' manufacturing and utilities' adoption. This aligns incentives with industry players and limits Lightbridge's need for heavy manufacturing capex.
Governance And Management ContinuityStrong shareholder support for directors, executive pay, and auditor ratification preserves leadership continuity through long regulatory and commercialization cycles. Stable governance reduces execution risk on multi-year qualification, partnership, and licensing processes.
Bears Say
Pre-revenue, Widening Net LossesPersistent absence of commercial revenue and materially widening losses indicate the technology has not yet converted to sales. Over multi-month horizons this undermines margin sustainability and signals that continued R&D and qualification costs may need external financing, pressuring long-term viability.
Negative Operating Cash Flow And Rising Cash BurnGrowing negative OCF and rising annual cash burn create structural funding risk: absent revenue, the company must repeatedly access capital markets. Even with no debt, reliance on equity raises risks dilution and can constrain investment in critical long-lead activities like irradiation testing and regulatory submissions.
Very Limited Internal Scale (small Team)A tiny headcount limits in-house capabilities for engineering, regulatory affairs, and commercialization oversight. Long-term commercialization of nuclear fuel typically requires deep technical, testing and regulatory teams; limited scale raises execution risk and increases dependence on partners to deliver key milestones.
Lightbridge News
N7ON FAQ
What was Lightbridge’s price range in the past 12 months?
Lightbridge lowest stock price was €7.37 and its highest was €24.55 in the past 12 months.
What is Lightbridge’s market cap?
Lightbridge’s market cap is €278.13M.
When is Lightbridge’s upcoming earnings report date?
Lightbridge’s upcoming earnings report date is Aug 17, 2026 which is in 64 days.
How were Lightbridge’s earnings last quarter?
Lightbridge released its earnings results on Apr 27, 2026. The company reported -€0.17 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.17.
Is Lightbridge overvalued?
According to Wall Street analysts Lightbridge’s price is currently Overvalued.
Does Lightbridge pay dividends?
Lightbridge does not currently pay dividends.
What is Lightbridge’s EPS estimate?
Lightbridge’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lightbridge have?
Lightbridge has 35,147,060 shares outstanding.
What happened to Lightbridge’s price movement after its last earnings report?
Lightbridge reported an EPS of -€0.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.224%.
Which hedge fund is a major shareholder of Lightbridge?
Currently, no hedge funds are holding shares in DE:N7ON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lightbridge Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.88%
12-Months-Change
Fundamentals
Return on Equity
-12.59%
Trailing 12-Months
Asset Growth
275.62%
Trailing 12-Months
Company Description
Lightbridge
Lightbridge Corporation, alongside its affiliated entities, specializes in the innovation and advancement of nuclear fuel technology, marketed under the "Lightbridge Fuel" brand. The company's core mission involves the creation and commercialization of advanced metallic nuclear fuels. These fuels are engineered to improve the durability and safety of nuclear energy generation in both current and future reactor designs, ultimately aiming to make a significant contribution to combating climate change and reducing atmospheric pollutants. Established initially as Thorium Power, Ltd., the organization rebranded as Lightbridge Corporation in September 2009. The company's headquarters are situated in Reston, Virginia.
N7ON Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong technical progress and a materially improved financial position, highlighted by the start of ATR irradiation testing, validated fabrication milestones, expanded INL scope and technical publications, and a cash balance that increased to $201.9 million (approximately +405% year-over-year) funded largely by a $176.0 million equity raise. At the same time, the company remains pre-commercial with significant regulatory, testing, and licensing work still required, used $14.3 million in operations in fiscal 2025, and faces timeline and execution risks tied to future post-irradiation examination and NRC engagement. Overall, positive execution and funding momentum outweigh near-term development and regulatory uncertainties.View all DE:N7ON earnings summariesTechnical Analysis
Options Prices
Currently, No data available
---